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in the absence of Ang II with losartan in the bath, the afferentAngiotensin II enhances tubuloglomerular feedback via lumi-
arteriole diameter decreased by 2.8  0.5 m (from 19.3 nal AT1 receptors on the macula densa.
1.2 to 16.5  0.8 m). After Ang II was added to the maculaBackground. Recent studies have revealed angiotensin II
densa perfusate and losartan to the bath, the diameter de-subtype 1 (AT1) receptors on macula densa cells, raising the
creased by 4.0  0.7 m (from 18.9  1.1 to 14.9  0.5 m,possibility that angiotensin II (Ang II) could enhance tubulo-
P  0.01 vs. TGF with no Ang II in the lumen and losartanglomerular feedback (TGF) by affecting macula densa cell func-
in the bath, N  8).tion. We hypothesized that Ang II enhances TGF via activation
Conclusions. These results demonstrate that Ang II en-of AT1 receptors on the luminal membrane of the macula densa.
hances TGF via activation of AT1 receptors on the luminalMethods. Rabbit afferent arterioles and the attached macula
membrane of the macula densa.densa were simultaneously microperfused in vitro, keeping
pressure in the afferent arteriole at 60 mm Hg.
Results. The afferent arteriole diameter was measured while
the macula densa was perfused with low NaCl (Na, 5 mmol/L; Afferent arteriole constriction induced by increasingCl, 3 mmol/L) and then with high NaCl (Na, 79 mmol/L;
the NaCl concentration at the macula densa is known asCl, 77 mmol/L) to induce a TGF response. When TGF was
tubuloglomerular feedback (TGF). Macula densa cells,induced in the absence of Ang II, the afferent arteriole diame-
ter decreased by 2.4  0.5 m (from 17.3  1.0 to 14.9  1.2 which are located within the cortical thick ascending
m). With Ang II (0.1 nmol/L) present in the lumen of the limb, function as the sensor of TGF, detecting changes
macula densa, the diameter decreased by 3.8  0.7 m (from in luminal fluid NaCl concentration and signaling the17.3  1.0 to 13.5  1.2 m, P  0.05 vs. TGF with no Ang
afferent arteriole, the effector of TGF [1–3]. TGF isII, N 8). To test whether Ang II enhances TGF via activation
important for regulation of glomerular filtration rateof AT1 receptors on the luminal membrane of the macula
densa, Ang II plus losartan (1 mol/L) was added to the lumen. (GFR) and thus fluid and electrolyte homeostasis, and
Losartan itself did not alter TGF. When TGF was induced consequently maintenance of blood pressure [4, 5]. TGF-
in the absence of Ang II and losartan, the afferent arteriole induced changes in glomerular capillary pressure anddiameter decreased by 2.3 0.3 m (from 15.9 1.0 to 13.6
GFR can be modified by a number of factors, including1.2 m). When Ang II and losartan were both present in the
autacoids and hormones [6–10].macula densa perfusate, the diameter decreased by 2.4  0.4
m (from 15.8  0.9 to 13.4  0.7 m, P  0.8 vs. TGF with Angiotensin II (Ang II) has important effects on the
no Ang II and losartan, N  7). We then examined whether kidney, including regulation of renal vascular resistance
AT2 receptors on the macula densa influence the effect of and GFR [11, 12] and tubular epithelial transport [13–15].luminal Ang II on TGF. When TGF was induced in the absence
Ang II in the renal circulation also potentiates TGFof Ang II plus PD 0123319-0121B (1 mol/L), the afferent
[7, 16]. Ang II may enhance TGF by acting on the maculaarteriole diameter decreased by 2.4  0.2 m (from 17.0 
0.9 to 14.6  0.8 m). When Ang II and PD 0123319-0121B densa or/and afferent arteriole (Af-Art), since both have
were both present in the macula densa lumen, the diameter been reported to express Ang II receptors [10, 16–20].
decreased by 3.9  0.2 m (from 16.8  0.9 to 12.9  0.9 m, Ang II actions are mediated by at least two types of Ang IIP  0.001 vs. TGF with no Ang II and PD 0123319-0121B,
receptors, AT1 and AT2 [21]. Losartan can bind to andN  8). PD 0123319-0121B itself had no effect on TGF. To
inactivate the AT1 receptors, whereas PD 0123319-0121Bassure that this effect of Ang II was not due to leakage into the
bath, losartan was added to the bath. When TGF was induced is commonly used as an antagonist for the AT2 receptors.
Most of the known physiological effects of Ang II seem
to be mediated by the AT1 receptors, while the physio-Key words: rabbit, afferent arterioles, glomerular hemodynamics, mi-
croperfusion, NaCl concentration, fluid and electrolyte homeostasis. logical role of the AT2 receptors has not been completely
clarified [22].Received for publication February 26, 2001
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corresponding plasma concentrations [23–25]. Thus, lu- equilibration period was allowed before any measure-
ments were taken.minal Ang II may exert a variety of influences on renal
function. In particular, it has been shown to increase Microperfusion of the end of the distal convoluted
tubule was started with low-NaCl solution containing thetransport in isolated perfused tubular segments containing
the macula densa; however, this preparation lacked the following composition (in mmol/L): 10 HEPES, 3 KCl,
1.2 MgSO4, 2 K3PO4, 5 NaHCO3, 5.5 glucose, and 1 cal-afferent arteriole and therefore TGF was not studied
[26, 27]. We tested the hypothesis that Ang II enhances cium lactate (pH 7.4). The high-NaCl solution had the
same composition except that 74 mmol/L NaCl wasTGF via activation of AT1 receptors on the luminal mem-
brane of the macula densa. Rabbit afferent arterioles added; thus, the final concentration was 79 mmol/L Na
and 77 mmol/L Cl.and the attached macula densa were simultaneously mi-
croperfused in vitro in order to examine the effect of Images were displayed at magnifications up to 1980
and recorded with a Sony video system (Tokyo, Japan)Ang II in the macula densa on TGF and its response to
(1) the AT1 antagonist losartan and (2) the AT2 antago- consisting of a camera (DXC-755), monitor (PVM1342Q),
and video recorder (EDV-7500). TGF was defined as thenist PD 0123319-0121B (PD).
change in afferent arteriole diameter when the NaCl con-
centration perfusing the macula densa was increased from
METHODS
low to high. Diameter was measured with an image analy-
Methods similar to those described previously were sis system (Universal Imaging, West Chester, PA, USA).
used to isolate and microperfuse the afferent arteriole Angiotensin II was purchased from Sigma; losartan
with attached glomerulus and macula densa [28, 29]. was a generous gift from Dupont Merck (Wilmington,
Briefly, male New Zealand White rabbits (weighing 1.4 DE, USA), and PD 0123319-0121B was a generous gift
to 2.2 kg) were fed standard rabbit chow with 0.34% Na from Parke Davis Pharmaceutical Research (Ann Arbor,
and 0.40% Cl (Ralston Purina, St. Louis, MO, USA) MI, USA).
and given tap water ad libitum. Animals were anesthe-
tized with ketamine plus xylazine (50 mg/kg and 10 mg/kg Statistics
IM) and sodium pentobarbital (30 mg/kg IV). Heparin Data are expressed as mean  SEM. Data were ana-
(500 U IV) was injected to block coagulation. The kid- lyzed using analysis of variance for repeated measures.
neys were removed and sliced along the longitudinal Post hoc testing was performed using paired t tests. The
corticomedullary axis. Slices were placed in ice-cold min- Hochberg method was used to adjust for multiple testing.
imum essential medium (MEM; Gibco, Grand Island, P  0.05 was considered significant.
NY, USA) containing 5% bovine serum albumin (BSA;
Sigma, St. Louis, MO, USA) and dissected under a ste-
RESULTSreomicroscope (SZH; Olympus, Tokyo, Japan). From
each rabbit, a single superficial afferent arteriole and First, we investigated the effect of Ang II in the macula
densa lumen on TGF. In the absence of Ang II, theits intact glomerulus were microdissected together with
adherent tubular segments consisting of portions of the afferent arteriole diameter decreased from 17.3  1.0 to
14.9  1.2 m when the NaCl concentration at the mac-thick ascending limb, macula densa, and early distal tu-
bule. Using a micropipette, the sample was transferred ula densa was changed from low to high (Fig. 1), resulting
in a TGF response of 2.4  0.5 m (Table 1). Whento a temperature-regulated chamber mounted on an in-
verted microscope (IMT-2; Olympus, Tokyo, Japan) with the perfusate was restored to low NaCl, the diameter
returned to baseline. When Ang II (0.1 nmol/L) wasHoffman modulation. Both the afferent arteriole and
the end of the distal convoluted tubule were cannulated added to the perfusate together with low NaCl, there
was no change. In the presence of Ang II, changing thewith an array of glass pipettes as described previously
[28, 29]. Intraluminal pressure of the afferent arteriole NaCl concentration decreased the diameter from 17.3 
1.0 to 13.5  1.2 m, resulting in a TGF response ofwas measured by Landis’ technique, using a fine pipette
introduced into the lumen through the perfusion pipette. 3.8  0.7 m (P  0.05 vs. TGF with no Ang II, N 
8; Table 1).The afferent arteriole was perfused with oxygenated
MEM (100% O2) containing 5% BSA, and intraluminal To investigate whether Ang II enhances TGF via acti-
vation of AT1 receptors on the luminal membrane of thepressure was maintained at 60 mm Hg throughout the
experiment. macula densa, the TGF response in the presence and
absence of Ang II plus losartan (an AT1 antagonist;The bath was MEM containing 0.15% BSA and was
exchanged continuously at a rate of 1 mL/min. Microdis- 1 mol/L) was compared in the macula densa perfusate.
During the control period, afferent arteriole diametersection and cannulation were completed within 90 min-
utes at 8	C, after which the bath was gradually warmed decreased from 15.9  1.0 to 13.6  1.2 m (Fig. 2),
resulting in a TGF response of 2.3  0.3 m (Table 1).to 37	C. Once the temperature was stable, a 30-minute
Wang et al: Angiotensin II and TGF 1853
Fig. 1. Effect of angiotensin II (Ang II) in the macula densa lumen
on afferent arteriole diameter (N 8, **P 0.01 vs. low NaCl;P Fig. 2. Effect of Ang II with the Ang II subtype 1 (AT1) receptor0.001 vs. low NaCl plus Ang II). MD is macula densa. antagonist losartan in the macula densa lumen on afferent arteriole
diameter (N 7, ***P 0.001 vs. low NaCl; P  0.01 vs. low NaCl
plus Ang II with losartan). Abbreviations are: MD, macula densa; Los,
losartan.
Table 1. Effect of angiotensin II (Ang II) and Ang II receptor antagonists on tubuloglomerular feedback (TGF)
Ang II Ang II  Los Ang II  PD Ang II (MD lumen) Ang II 
(MD lumen) (MD lumen) (MD lumen)  Los (bath) Ang II (bath) Los (bath)
Control TGF lm 2.40.5 2.30.3 2.40.2 2.80.5 2.40.2 2.50.2
Treatment TGF lm 3.80.7a 2.40.4 3.90.2c 4.00.7b 4.20.6a 2.30.1
N 8 7 8 8 5 5
Values are mean  SE. Abbreviations are: N, number; Los, losartan; MD, macula densa; PD, PD 0123319-0121B.
a P  0.05, bP  0.01, cP  0.001 vs. control TGF
When Ang II (0.1 nmol/L) and losartan were added to TGF. Under control conditions, the afferent arteriole di-
ameter decreased from 17.0 0.9 to 14.6 0.8 m whenthe perfusate, the diameter decreased from 15.8  0.9
to 13.4  0.7 m, resulting in a TGF response of 2.4  the NaCl concentration at the macula densa was increased
(Fig. 4), yielding a TGF response of 2.4 0.2m (Table 1).0.4 m (P  0.8 vs. TGF with no Ang II and losartan,
N  7; Table 1). To determine whether losartan itself After adding Ang II (0.1 nmol/L) plus PD 0123319-
0121B (an AT2 antagonist; 1mol/L) to the macula densaalters TGF, we examined the influence of losartan in the
macula densa lumen on TGF. In the absence of losartan, lumen, the diameter decreased from 16.8 0.9 to 12.9
0.9 m, yielding a TGF response of 3.9  0.2 m (P afferent arteriole diameter decreased from 16.3  1.4 to
14.0  1.2 m when the NaCl concentration at the mac- 0.001 vs. TGF with no Ang II and PD 0123319-0121B,
N  8; Table 1). PD 0123319-0121B itself had no effectula densa was changed from low to high (Fig. 3); after
losartan was added to the perfusate, diameter decreased on TGF. In the absence and presence of PD 0123319-
0121B in the macula densa lumen, TGF was 2.7  0.9from 16.4  1.6 to 14.4  1.6 m (N  5). Thus, there
was no difference in TGF response between the two and 2.7  0.6 m, respectively (P  0.9, N  4).
To assure that the effect of Ang II was not due toperiods.
We next examined whether AT2 receptors on the lu- leakage into the bath affecting the afferent arteriole and
the basolateral membrane of the macula densa cells,men of the macula densa influence the effect of Ang II on
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Fig. 4. Effect of Ang II with the AT2 antagonist PD 0123319-0121B
in the macula densa lumen on afferent arteriole diameter (N  8;Fig. 3. Effect of losartan in the macula densa lumen on afferent arteri-
***P  0.001 vs. low NaCl; P  0.001 vs. low NaCl plus Ang IIole diameter (N 5; **P 0.01 vs. low NaCl;P 0.01 vs. low NaCl
with PD 0123319-0121B). Abbreviations are: MD, macula densa; PD,plus losartan). Abbreviations are: MD, macula densa; Los, losartan.
PD 0123319-0121B.
the experiment was repeated with losartan in the bath.
luminal membrane of the macula densa, TGF was mea-Under control conditions, the afferent arteriole diameter
sured after adding Ang II and losartan to the maculadecreased from 19.3 1.2 to 16.5 0.8 m; after Ang II
densa lumen, and found to be not significantly different(0.1 nmol/L) was added to the macula densa perfusate
from the control value. This indicates that the augmen-with losartan in the bath, the diameter decreased from
tation of TGF induced by Ang II was prevented by coad-19.0  1.1 to 15.0  0.5 m (Fig. 5). During the control
ministration of losartan, although losartan alone did notperiod, TGF was 2.8  0.5 m; after adding Ang II to
alter TGF. We also tested whether luminal AT2 receptorsthe macula densa lumen with losartan in the bath, it was
on the macula densa influence the effect of luminal Ang II4.0  0.7 m (P  0.01 vs. TGF; with no Ang II and lo-
on TGF, using the AT2 receptor antagonist PD 0123319-sartan, N 8; Table 1). To determine whether 1 mol/L
0121B to block the AT2 receptors. A comparison of TGFlosartan can block potentiation of the effect of 0.1 nmol/L
response between control conditions and Ang II plus PDAng II on TGF, an additional experiment was per-
0123319-0121B in the macula densa lumen suggested thatformed. Without Ang II in the bath, TGF was 2.4 
the AT2 receptors do not influence the effect of Ang II0.2 m (from 16.8  0.7 to 14.4  0.5 m); after adding
on TGF. Thus, it appears likely that in macula densaAng II to the bath, it was 4.2  0.6 m (from 16.1 
cells Ang II enhances TGF via activation of AT1 receptors0.6 to 11.9  0.9 m; P  0.05 vs. no Ang II TGF, N 
on the luminal membrane. To make sure this effect was5; Table 1). In the absence and presence of Ang II plus
not due to Ang II entering the bath and affecting thelosartan in the bath, TGF was 2.5 0.2 and 2.3 0.1m,
afferent arteriole and the basolateral membrane of therespectively (P  0.4, N  5; Table 1). This losartan
macula densa cells, we added the AT1 antagonist losartanconcentration completely blocked the ability of Ang II
to the bath to block AT1 receptors at both sites. We foundin the bath to augment TGF.
that 1 mol/L losartan completely blocked the effect of
Ang II in the bath to augment TGF, and yet Ang II in
DISCUSSION the macula densa lumen still augmented TGF.
Tubuloglomerular feedback is an important regulatorOur findings suggest that Ang II in the macula densa
lumen augments the TGF response. To test whether Ang of glomerular filtration rate. Ang II in the renal circula-
tion is considered to be a modulator of TGF and hasII enhances TGF via activation of AT1 receptors on the
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activity is higher in the early proximal tubule and dimin-
ishes as one moves down the nephron, it is likely that a
large amount of the Ang II present in the late proximal
tubule remains intact during passage through the loop
of Henle and into the distal nephron. However, micro-
puncture studies demonstrating this have not been pub-
lished to our knowledge.
Angiotensin II exerts its effects via two receptor sub-
types designated AT1 and AT2. The AT1 receptor stimu-
lates transport and causes vasoconstriction [30–32], while
the AT2 receptor is thought to inhibit transport and in-
duce vasodilation [11, 32, 33]. Poumarat et al found AT1
receptors on the luminal surface of medullary thick as-
cending limb cells (abstract; Poumarat et al, J Am Soc
Nephrol 11:427A, 2000). Immunohistochemical studies
revealed AT1 receptors on macula densa cells [20]. The
immunohistochemical photomicrographs appear to show
staining throughout the entire cell, although the basolat-
eral aspect is clearly more heavily stained than the apical
aspect. Ang II has been shown to stimulate transport by
activating AT1 receptors on both the basolateral [26, 27]
and luminal membranes of the macula densa [27]. Thus,
Ang II may modulate the TGF signal transmission pro-
Fig. 5. Effect of Ang II in the macula densa lumen plus losartan in cess at least partially through an effect on the luminal
the bath on afferent arteriole diameter (N  8; ***P  0.001 vs. low membrane of the macula densa. Schnermann et al foundNaCl; P  0.001 vs. low NaCl plus Ang II in the macula densa
that TGF responses were severely inhibited in AT1A re-lumen with losartan in the bath). Abbreviations are: MD, macula densa;
Los, losartan. ceptor-deficient mice, which clearly emphasized the criti-
cal role of Ang II in determining the magnitude of the
TGF response. However, these data also indicate that
TGF is mediated by the AT1A receptors [34]. This conclu-been shown to augment feedback responses. Mitchell
sion is at odds with our own study and others.
and Navar showed that peritubular capillary infusion of The data of Schnermann et al showing little or no
Ang II enhances the sensitivity of the TGF mechanism TGF response in AT1A receptor knockout mice can be[7]. Ploth and Roy studied the effect of acute blockade explained in many ways. First, it could be that angioten-
of the renin-angiotensin system on TGF response and sin mediates TGF and thus is necessary for this process.
found that angiotensin is most likely a modulating influ- This seems unlikely given the numerous contrary in vivo
ence on the activity of the system, rather than a mediator and in vitro studies. Second, angiotensin could be permis-
of feedback-induced changes in glomerular function [8]. sive, but not the mediator. This also seems unlikely given
Schnermann and Briggs reported that the renin-angio- the numerous in vitro studies demonstrating TGF in the
tensin system does not mediate TGF-dependent vaso- absence of exogenously added angiotensin. One way to
constriction; however, acute changes in plasma Ang II reconcile these disparate results is to conclude that suffi-
exert an important modifying effect on the feedback cient angiotensin is generated by the preparation to allow
response [9]. Our present data show that Ang II in the TGF to occur. We believe that the most likely explana-
macula densa lumen augments the TGF response. tion for the results of Schnermann et al is neither of
Angiotensin is a powerful vasoconstrictor, and when these, but rather that angiotensin is essential for normal
added to the renal circulation has been shown to aug- development of the kidney. The kidneys of AT1A knock-
ment TGF [7, 16–19]. However, in these studies the an- out mice show significant histological differences from
giotensin concentration of the vessel lumen was changed, wild-type controls, primarily in the vasculature. While
whereas our study showed an effect of Ang II on the we do not understand the full impact of these histological
luminal membrane. Given the size of Ang II, it is unlikely differences, it is easy to speculate that elimination of
that it crosses the epithelium; thus it is necessary to the AT1A receptor leads to alterations in the signaling
identify a luminal source of Ang II. cascade for adenosine that several investigators have
Studies by Navar et al and Seikaly et al have shown shown to be essential for TGF.
that Ang II levels are significantly higher in the proximal The present study also demonstrated that the enhance-
ment of TGF induced by Ang II in the bath was equiva-tubular fluid than in plasma [23–25]. Given that peptidase
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